|
CLPTM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30930044583977E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62503344114384E-12 |
| Normal-vs-Stage2 |
7.84289999611332E-08 |
| Normal-vs-Stage3 |
3.959800E-04 |
| Normal-vs-Stage4 |
3.757000E-04 |
| Stage1-vs-Stage2 |
7.551200E-01 |
| Stage1-vs-Stage3 |
3.316400E-02 |
| Stage1-vs-Stage4 |
6.043200E-01 |
| Stage2-vs-Stage3 |
5.693800E-02 |
| Stage2-vs-Stage4 |
5.309200E-01 |
| Stage3-vs-Stage4 |
3.689600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.98829999528994E-09 |
| Normal-vs-AfricanAmerican |
1.20390364344303E-11 |
| Normal-vs-Asian |
2.164600E-03 |
| Caucasian-vs-AfricanAmerican |
8.040600E-01 |
| Caucasian-vs-Asian |
9.513800E-01 |
| AfricanAmerican-vs-Asian |
9.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.33790020465597E-10 |
| Normal-vs-Female |
1.83939996567517E-09 |
| Male-vs-Female |
3.291800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.93709997726211E-09 |
| Normal-vs-Extreme_Weight |
2.5076996035267E-10 |
| Normal-vs-Obese |
3.72980000218348E-08 |
| Normal-vs-Extreme_Obese |
1.87707000000037E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.095440E-01 |
| Normal_Weight-vs-Obese |
5.884200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.126800E-01 |
| Extreme_Weight-vs-Obese |
2.550100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.842000E-01 |
| Obese-vs-Extreme_Obese |
2.910800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.993200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.33379973732417E-11 |
| Normal-vs-Age(61-80Yrs) |
4.2462999783055E-10 |
| Normal-vs-Age(81-100Yrs) |
1.44339999952336E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.447400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.299400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.131400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.124400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.427400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.913600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.79280043535834E-10 |
| Normal-VS-Type2 PRCC |
1.18730000275846E-08 |
| Normal-VS-KIRP CIMP |
1.515830E-03 |
| Normal-VS-Unclassified PRCC |
7.291800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.167830E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.837500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.000210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.149200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.613600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.028000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.139100E-03 |
| Normal-vs-N1 |
4.60440000005224E-06 |
| Normal-vs-N2 |
4.494000E-02 |
| N0-vs-N1 |
5.410000E-01 |
| N0-vs-N2 |
9.299200E-01 |
| N1-vs-N2 |
8.046200E-01 |
|
|
